Official opening of the MabMine antibody discovery platform at KUL
On the 27th of May was the official opening of the novel MabMine antibody discovery platform at Campus Gasthuisberg in Leuven with the participation of about 60 invited academic and industrial collaborators.
The new facility is dedicated to advancing the MabMine antibody discovery platform and is equipped with state-of-the-art technology for:
-
Single B cell screening and isolation;
-
B cell receptor (BCR) sequencing;
-
Recombinant antibody production
-
Antibody characterization.
New Lab Supported by Vlaamse Veerkracht/ NextGenerationEU Grant — PharmAbs
B-specific projects were also highlighted at the event!
